Orphan designation: selinexor Treatment of chronic lymphocytic leukaemia / small lymphocytic lymphoma, 19/11/2014 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 May 2026 - 9:03

Orphan designation: selinexor Treatment of chronic lymphocytic leukaemia / small lymphocytic lymphoma, 19/11/2014 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-14-1354

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters